5 minutes with Practice Manager Sherrie D'Souza
15 May 2015
Practice Manager of six over two locations, Sherrie D’Souza is a highly valued staff member at MIA. We sat down with her to get some insight into a day in the life of her role and what inspires her.
Can you tell us a bit about your role?
I am the Practice Manager of six, over two locations, MIA and RPA as well as 17 Doctors across both those locations as well. I supervise the administrative management of the clinics at these locations including staffing, finance and other practice matters.
What drives you to come to work?
The opportunity to make life a little bit easier for our patients and if we can put a smile on their faces, as secretaries that is a great day.
How do you stay positive?
It is easy to stay positive because our patients are positive. They have a fierce positivity that doesn’t show any boundaries, there is no way we can be negative when we are seeing such amazing results. How far the research has come also inspires such positivity as we can see how we are changing lives daily.
Explain the team environment within the clinic
The Doctors are incredible and passionate and happy to share their knowledge and foster an environment of learning. The secretaries are feeding off the energy, they give that bit extra and I am lucky to work with such an incredible team, it is so enjoyable to work with such great people. It doesn’t feel like a job to me, it is my life and I love it.
What do you like to do in your spare time?
I love spending time with my husband and my cat; I also love my hobbies like cross-stitch. I like to have lots going on, I don’t like having idle hands, and I am always looking for my next project to do!
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.